Company Updates

Antisense Therapeutics (ANP) has advised that the ATL1102 for Multiple Sclerosis (MS) Phase IIb IND application has been submitted to the US Food and Drug Administration (FDA) for its review.

Antisense Therapeutics has announced that the company has undertaken advanced planning for the clinical trial of ALT1102.

Cre8tek Limited (ASX: CR8), owner of high-tech, Artificial Intelligence company and Cognitive Virtual Assistant platform provider, Flamingo Customer Experience Inc.

Trustee Tailored Super (TTS) provides Australia’s 100 largest superannuation trustees an IP protected better solution compared to the current default option choices.

Collaborate Corporation Limited (ASX:CL8) has announced that DriveMyCar business unit has expanded its successful relationship with Subaru Australia.

iFAST Financial Pte Ltd, Singapore subsidiary of SGX-ST Mainboard-list iFAST Corporation Ltd. iFAST Corp, has added trading capabilities in the SGX-listed stocks and Exchange Traded Funds on FSMOne.

Data Solutions company Invigor Group (ASX:IVO) is planning to raise $2.5 million via the issue of convertible notes to sophisticated investors to fund its growth strategy.

Thinxtra, founded in 2015, holds licences for Australia, New Zealand and Hong Kong to proprietary low powered wide area network (LPWAN) wireless technology for IoT from French company Sigfox.

The platform, BALLR is bring excitement to fans across Asia, with Manchester United legends Ryan Giggs, Paul Scholes, Gary and Phil Neville and Nicky Butt.